110 related articles for article (PubMed ID: 7561888)
1. Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo.
Schmid L; Bottlaender M; Fuseau C; Fournier D; Brouillet E; Mazière M
J Neurochem; 1995 Oct; 65(4):1880-6. PubMed ID: 7561888
[TBL] [Abstract][Full Text] [Related]
2. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
Benavides J; Peny B; Ruano D; Vitorica J; Scatton B
Brain Res; 1993 Feb; 604(1-2):240-50. PubMed ID: 8096157
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone.
Byrnes JJ; Greenblatt DJ; Miller LG
Brain Res Bull; 1992 Dec; 29(6):905-8. PubMed ID: 1361878
[TBL] [Abstract][Full Text] [Related]
4. Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; Nutt DJ
J Cereb Blood Flow Metab; 2002 Jul; 22(7):878-89. PubMed ID: 12142573
[TBL] [Abstract][Full Text] [Related]
5. The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem.
McLeod M; Pralong D; Copolov D; Dean B
Brain Res Mol Brain Res; 2002 Aug; 104(2):203-9. PubMed ID: 12225875
[TBL] [Abstract][Full Text] [Related]
6. In vivo high intrinsic efficacy of triazolam: a positron emission tomography study in nonhuman primates.
Bottlaender M; Brouillet E; Varastet M; Le Breton C; Schmid L; Fuseau C; Sitbon R; Crouzel C; Mazière M
J Neurochem; 1994 Mar; 62(3):1102-11. PubMed ID: 8113798
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization of [3H]zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites.
Niddam R; Dubois A; Scatton B; Arbilla S; Langer SZ
J Neurochem; 1987 Sep; 49(3):890-9. PubMed ID: 3039057
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Benavides J; Peny B; Durand A; Arbilla S; Scatton B
J Pharmacol Exp Ther; 1992 Nov; 263(2):884-96. PubMed ID: 1331419
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS.
Mehta AK; Shank RP
Brain Res; 1995 Dec; 704(2):289-97. PubMed ID: 8788925
[TBL] [Abstract][Full Text] [Related]
10. High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors.
Arbilla S; Allen J; Wick A; Langer SZ
Eur J Pharmacol; 1986 Nov; 130(3):257-63. PubMed ID: 2878820
[TBL] [Abstract][Full Text] [Related]
11. Synchronous postnatal increase in alpha1 and gamma2L GABA(A) receptor mRNAs and high affinity zolpidem binding across three regions of rat brain.
Roberts AA; Kellogg CK
Brain Res Dev Brain Res; 2000 Jan; 119(1):21-32. PubMed ID: 10648869
[TBL] [Abstract][Full Text] [Related]
12. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
Massotti M; Schlichting JL; Antonacci MD; Giusti P; Memo M; Costa E; Guidotti A
J Pharmacol Exp Ther; 1991 Mar; 256(3):1154-60. PubMed ID: 1848629
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in the enhancement by GABA of [3H]zolpidem binding to omega 1 sites in rat brain membranes and sections.
Ruano D; Benavides J; Machado A; Vitorica J
Brain Res; 1993 Jan; 600(1):134-40. PubMed ID: 8380746
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats.
Arbilla S; Depoortere H; George P; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):248-51. PubMed ID: 2997631
[TBL] [Abstract][Full Text] [Related]
15. Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography.
Abadie P; Rioux P; Scatton B; Zarifian E; Barré L; Patat A; Baron JC
Eur J Pharmacol; 1996 Jan; 295(1):35-44. PubMed ID: 8925872
[TBL] [Abstract][Full Text] [Related]
16. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.
Benavides J; Peny B; Dubois A; Perrault G; Morel E; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1988 Jun; 245(3):1033-41. PubMed ID: 2838599
[TBL] [Abstract][Full Text] [Related]
17. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem.
Dennis T; Dubois A; Benavides J; Scatton B
J Pharmacol Exp Ther; 1988 Oct; 247(1):309-22. PubMed ID: 2845057
[TBL] [Abstract][Full Text] [Related]
18. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
Dean B; Scarr E; McLeod M
Brain Res Mol Brain Res; 2005 Aug; 138(2):145-55. PubMed ID: 15950312
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the allosteric interaction between the gamma-aminobutyric acid (GABA) binding site and three different benzodiazepine binding sites of the GABAA/benzodiazepine receptor complex in the rat nervous system.
Ruano D; Vizuete M; Cano J; Machado A; Vitorica J
J Neurochem; 1992 Feb; 58(2):485-93. PubMed ID: 1309562
[TBL] [Abstract][Full Text] [Related]
20. Modulation of [35S]TBPS binding by ligands with preferential affinity for benzodiazepine BZ1 sites in the cerebral cortex of newborn and adult rats.
Giorgi O; Lecca D; Cancedda E; Serra GP; Corda MG
Eur J Pharmacol; 1995 Jun; 290(1):37-47. PubMed ID: 7664823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
